PMS64 - Cost-Utility Analysis of Apremilast for The Treatment of Psoriatic Arthritis Patients In Spain

Autor: Gonzalez, CM, Almodóvar, R, Caloto, T, Echave, M, Elías, I, Tencer, T
Zdroj: In Value in Health November 2015 18(7):A645-A645
Databáze: ScienceDirect